• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Benign Prostatic Hyperplasia: Diagnosis and Treatment

Benign Prostatic Hyperplasia: Diagnosis and Treatment

AHCPR Clinical Practice Guidelines, No. 8

, , and .

Rockville (MD): Agency for Health Care Policy and Research (AHCPR); .
Report No.: 94-0582

This Clinical Practice Guideline makes specific recommendations to identify both the most effective methods for diagnosing benign prostatic hyperplasia (BPH) and the most appropriate treatments for BPH based on patient preference and clinical need.

The most important risk factors for the development of BPH are poorly understood. This guideline represents the most current scientific knowledge regarding its development, diagnosis, and treatment.

Guideline recommendations target two overall goals: (1) identifying the most appropriate and effective diagnostic methods for detecting BPH and gauging its severity and (2) selecting the most appropriate treatment approach. BPH is a disease that affects a patient's quality of life. The guideline emphasizes that since BPH is very rarely a life-threatening disease, many patients may choose a regimen of "watchful waiting" rather than more active treatments. This is an appropriate choice for many patients. Motivation to seek active treatment will, for most patients, depend on the degree to which their symptoms bother them. The guideline details the relative benefits and harms associated with all diagnostic and treatment approaches, including watchful waiting.

Discussed in the guideline are both invasive and noninvasive diagnostic methods: recommended, optional, and not recommended for BPH. Treatment options include watchful waiting, alpha blocker and finasteride medications, balloon dilation, and surgical options: transurethral incision, transurethral resection, and open prostatectomy. Among the still investigational methods for treating BPH are laser prostatectomy, thermal therapy, and other emerging modalities.


Suggested citation:

McConnell JD, Barry MJ, Bruskewitz RC, et al. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guideline, Number 8. AHCPR Publication No. 94-0582. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services. February 1994.

Bookshelf ID: NBK52272
PubReader format: click here to try


  • PubReader
  • Print View
  • Cite this Page

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...